1250_Genovese.pdf

1、See Important Safety Information referenced within.Information contained herein for DISPLAY in the U.S.ONLY.Not to be reproduced,distributed or excerpted.2025 Abbott.All rights reserved.MAT-2507761 v3.0Esprit BTK System:The Role of Drug-Eluting Resorbable Scaffolds for Infrapopliteal CLTISee Importa

2、nt Safety Information referenced within.Information contained herein for DISPLAY in the U.S.ONLY.Not to be reproduced,distributed or excerpted.2025 Abbott.All rights reserved.MAT-2507761 v3.0Device&Device OverviewDr.Sahil A.Parikh,MD,FSCAIAssociate Professor of Medicine;Director for Endovascular Ser

3、vices,Columbia University Irving Med CenterESPRITBTK SYSTEMSee Important Safety Information referenced within.Information contained herein for DISPLAY in the U.S.ONLY.Not to be reproduced,distributed or excerpted.2025 Abbott.All rights reserved.MAT-2507761 v3.0Unmet Need for BTKBTK PAD1Small vessel

4、diameterTortuous,challenging anatomyLonger lesion lengthSevere calcificationPOBASpecialty BalloonsAtherectomyIVLDESEsprit BTK DRSDRUG(Inhibit Neointimal Hyperplasia)SCAFFOLD(Resist Recoil)LEAVE NOTHING BEHIND*To effectively treat BTK PAD2Data on file at Abbott.*Excluding platinum markers1.Zeller T,e

5、t al.Orbital Atherectomy Prior to Drug-Coated Balloon Angioplasty in Calcified Infrapopliteal Lesions:A Randomized,Multicenter Pilot Study.Journal od Endovascular Therapy.2022;29(6):874-884.2.Varcoe R,et al.Primary Outcomes of the Esprit BTK Drug-Eluting Resorbable Scaffold for the Treatment of Infr

6、apopliteal Lesions:The LIFE-BTK Trial.Presented at TCT 2023.See Important Safety Information referenced within.Information contained herein for DISPLAY in the U.S.ONLY.Not to be reproduced,distributed or excerpted.2025 Abbott.All rights reserved.MAT-2507761 v3.0PROCEDURAL STEPSPRODUCT LOGISTICSCASE